- Report
- October 2024
- 82 Pages
Global
From €3500EUR$3,926USD£3,029GBP
Levomepromazine is an analgesic drug used to treat pain. It is a phenothiazine derivative, and is used to treat moderate to severe pain, including postoperative pain, cancer pain, and chronic pain. It is also used to treat nausea and vomiting, and is sometimes used as an adjunct to opioid analgesics. It is available in both oral and injectable forms.
Levomepromazine is generally well tolerated, with few side effects. Common side effects include drowsiness, dizziness, dry mouth, and constipation. It is contraindicated in patients with a history of glaucoma, and should be used with caution in patients with a history of cardiovascular disease.
The levomepromazine market is a small but growing segment of the analgesics market. It is used in a variety of settings, including hospitals, clinics, and home care. It is also used in combination with other analgesics, such as opioids, to provide more effective pain relief.
Some companies in the levomepromazine market include Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more